The following topics under the call H2020-JTI-IMI2-2014-01 are open:
IMI2-2014-01-01: Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM)
To address the complex tasks of the call adequately, the project is expected to build a pan-European clinical trial and translational research network including a clinical registry of eligible people with T1DM. Such network will include:
- Academic endocrine clinics and associated supporting departments
- Basic, translational, and clinical researchers from the fields of T1DM autoimmunity and β-cell biology,
- Drug discovery and medical staff in Pharmaceutical Industry and Small and Medium size Enterprises.
- Hands-on data base specialists and big data managers
- Patient organizations/representatives
- Experts in regulatory science and health technology assessment preferably representing European health authorities.
IMI2-2014-01-02: Discovery and validation of novel endpoints in dry age-related macular degeneration and diabetic retinopathy
The applicant consortium is expected to be multidisciplinary and have a proven track record of:
a.Strong clinical expertise in ophthalmology (including advanced examination techniques)
b.Strong clinical research experience
c.Access to patients and databases
d.Public health expertise
e.Health economic expertise
f.Understanding of pre-clinical models in ophthalmology
g.Biomarker expertise (biomarkers research and development)
h.Data and knowledge management
i.Regulatory, ethics, patients and project management
More Information available at:
